We are thrilled to announce that the Knut and Alice Wallenberg Foundation (KAW) is investing in patient-oriented clinical research across Sweden. This initiative will strengthen the four Wallenberg Centres for Molecular Medicine in Gothenburg, Lund, Linköping and Umeå, as well as leading environments at Karolinska Institutet and Uppsala University.
As part of this initiative, support is included for around 80 Clinical Fellows – physicians who will have the opportunity to both work clinically and conduct research. It is a joint effort where the involved universities and the regions connected to the Wallenberg Centres for Molecular Medicine (WCMM), as well as Karolinska Institutet and Uppsala University, co‑finance the research portion of the physicians’ positions.
“This is a powerful, long-term initiative to ensure that Swedish clinical research does not lose momentum. There have been signs that fewer physicians are conducting research, which is why we are very pleased that, together with the universities and regions, we can now offer the conditions needed for more people to engage in research,” says Peter Wallenberg Jr.
WCMM Lund, have been awarded an additional SEK 155 million for 2027–2039. “This funding will enable us to recruit new clinical research leaders, further strengthen our translational research environment and continue to build on our strong foundation, in close collaboration with Region Skåne,” says Gunilla Westergren-Thorsson. “We are very grateful for this opportunity and for the trust placed in WCMM Lund”
This long-term support will help us continue advancing molecular medicine and improving patient outcomes, both regionally and nationally.